
Keywords: Akt; protein kinase B; ATP; adenosine triphosphate; CK-MB; creatine kinase; EPO; erythropoietin; I/R; ischemia/reperfusion; IPC; ischemic preconditioning; IPOC; ischemic postconditioning; LDH; lactate dehydrogenase; LY294002; PI-3K inhibitor; mito KATP; m